Chat with us
PPTINIB Tablet contains Dasatinib, a prescription tyrosine kinase inhibitor (TKI) used in the treatment of certain types of leukemia. It works by blocking abnormal proteins (BCR-ABL and SRC family kinases) that promote the growth and spread of cancer cells, helping to slow or stop disease progression. Dasatinib is commonly prescribed for adults and children with Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and certain cases of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), as determined by an oncologist or hematologist. PPTINIB Tablets are manufactured under stringent quality standards and are available in multiple strengths to meet different treatment requirements. The tablets should be taken exactly as prescribed by a healthcare professional, with or without food, and treatment should not be discontinued without medical advice. Key Highlights Brand Name: PPTINIB Tablet Generic Name: Dasatinib Dosage Form: Oral Tablets Therapeutic Category: Anti-Cancer / Oncology Medicine Drug Class: Tyrosine Kinase Inhibitor (TKI) Indications: Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+ CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) Storage: Store below 30°C in a cool, dry place away from direct sunlight. Prescription Status: Prescription-only medicine. Use only under the supervision of a qualified healthcare professional.
